| Date | Title | Description |
| 29.05.2025 | Kyron.bio: Pioneering a New Era in Antibody Therapeutics | In the bustling world of biotechnology, a new player is making waves. Kyron.bio, a Paris-based startup, has secured €5.5 million in seed funding to revolutionize drug development. This funding is not just a financial boost; it’s a lifeline ... |
| 29.05.2025 | Kyron.bio Raises €5.5M in Funding | Kyron.bio, a Paris, France-based glycan engineering startup, raised €5.5m in funding.
The round was led by HCVC with participaiton from Verve Ventures, Entrepreneur First, and Saras Capital.
The company intends to use the funds to expand op... |
| 28.05.2025 | Kyron.bio raises €5.5M to transform antibody design | One of the biggest challenges facing biologic drug developers are varying efficacy and the dangers of side effects.
Biotechnology company Kyron.bio has raised €5.5 million funding to solve these issues using precise control of sugar molecul... |
| 28.05.2025 | Kyron.bio Secures $6.2M to Optimize Biologic Drug Development with Precision Glycan Engineering | What You Should Know:
– Biotechnology company kyron.bio announced the successful closing of a $6.2M (€5.5M) seed funding round aimed at solving critical challenges in biologic drug development, specifically varying efficacy and the dangers ... |
| 28.05.2025 | Paris-based kyron.bio secures €5.5 million to tackle drug efficiency and safety | French BioTech company kyron.bio announced today a €5.5 million Seed funding round to tackle the issues of varying efficacy and dangerous side effects in current drug development, using control of sugar molecules – also known as glycans.
Th... |
| - | Kyron.bio | “Home | Kyron.bio ” |